| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 09/23/2009 | CN101538243A Malononitrile compound and use thereof |
| 09/23/2009 | CN101538224A Process for preparing xanthine phosphodiesterase V inhibitors and precursers thereof |
| 09/22/2009 | US7592463 Enantioselective transformation of α,β-unsaturated ketones using chiral organic catalysts |
| 09/22/2009 | US7592456 Arylsulfonylnaphthalene derivatives as 5HT2A antagonists |
| 09/22/2009 | US7592449 Therapy for ischemic-repefusion injuries; liver disorders; antiarrhythmia agents; anticancer agents; astaxanthin |
| 09/22/2009 | US7592362 Substituted imidazoles |
| 09/17/2009 | WO2009113677A1 A low-corrosion ion liquid and a lubricating oil composition including same |
| 09/17/2009 | WO2009112677A2 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 09/17/2009 | WO2009071049A3 METHOD FOR PRODUCING PRECURSORS FOR L-3,4-DIHYDROXY-6-[18F]FLUOROPHENYLALANINE AND 2-[18F]FLUORO-L-TYROSINE AND THE α-METHYLATED DERIVATIVES THEREOF, PRECURSOR, AND METHOD FOR PRODUCING L-3,4 DIHYDROXY-6-[18F]FLUOROPHENYLALANINE AND 2-[18F]FLUORO-L-TYROSINE AND THE α-METHYLATED DERIVATIVES FROM THE PRECURSOR |
| 09/17/2009 | US20090233943 New compounds 835 |
| 09/17/2009 | US20090233929 Imidazole Derivatives for the Treatment of Anxiety and Related Diseases |
| 09/17/2009 | US20090230362 Conjugated oligoelectrolyte electron transporting layers |
| 09/17/2009 | DE102008014028A1 Preparing imidazolium salts, preferably 1,3-disubstiuted imidazolium salts, useful e.g. as precursors of N-heterocyclic carbenes, comprises reducing 1,3-disubstituted-2-alkoxyimidazolium salts with hydrides and/or hydride donors |
| 09/17/2009 | CA2712914A1 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 09/16/2009 | EP2100890A1 Novel polynitrogenated systems as anti-hiv agents |
| 09/16/2009 | EP2100876A2 New compounds for the inhibition of rotamases and use thereof |
| 09/16/2009 | EP2099769A1 6-oxo.-1, 6-dihydropyrimidin-2-yls in the treatment of proliferative diseases |
| 09/16/2009 | EP2099768A2 Agonists of the sphingosine-1-phosphate receptor |
| 09/16/2009 | EP1462444B1 Intermediate for biotin and process for producing the same |
| 09/16/2009 | EP1437338B1 Luminous compounds and labeling reagents using the same |
| 09/16/2009 | CN101535273A 6-oxo.-1, 6-dihydropyrimidin-2-yls in the treatment of proliferative diseases |
| 09/16/2009 | CN101535272A Method for preparing medetomidine and its salts |
| 09/16/2009 | CN101531637A A novel compound capable of restraining and blocking M2 ion channel activity and application thereof |
| 09/16/2009 | CN101531636A Method for synthesizing 2-(1-imidazol)ethylamine |
| 09/16/2009 | CN101531635A Imidazoline asymmetrical bi-quaternary ammonium salt, method for preparing same and application thereof |
| 09/16/2009 | CN100540547C Inhibitors of histone deacetylase |
| 09/16/2009 | CN100540538C Large conductance calcium-activated k channel opener |
| 09/15/2009 | US7589214 2-Cyclopentyl-4-(4-phenoxyphenyl)thiazole-5-carboxamide; amidation; oxidation; cyclization; |
| 09/15/2009 | US7589096 3-(3-biphenylyl)-5-[3-oxospiro[6-azaisobenzofuran-1(3H),4'-piperidin]-1'-yl]-1H-pyrazole; neuropeptide Y receptor antagonists; metabolic, genitalor reproductive, gastro-intestinal, respiratory system disorders, antiinflammatory agent or glaucoma; cyclization |
| 09/15/2009 | US7589094 N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 09/15/2009 | CA2429220C Gaba enhancers in the treatment of diseases relating to reduced neurosteroid activity |
| 09/15/2009 | CA2374471C Therapeutically and/or nutritionally enhanced derivatives of active ingredients and orally administrable compositions containing same |
| 09/15/2009 | CA2218699C 1,3-propane diol derivatives as bioactive compounds |
| 09/11/2009 | WO2009111061A1 Process for the preparation of sorafenib and salts thereof |
| 09/11/2009 | WO2009110499A1 Method for water purification, equipment for water purification, and water purification set |
| 09/11/2009 | WO2009110002A1 Novel efflux pump inhibitors |
| 09/10/2009 | US20090227604 Vitamin d receptor modulators |
| 09/10/2009 | US20090227592 Compounds effecting glucokinase |
| 09/09/2009 | EP2098528A2 Biotin intermediate and process for preparing the same |
| 09/09/2009 | EP2098515A1 Substituted carbinol compound |
| 09/09/2009 | EP2098514A1 Preparation of compounds useful for the detection of hypoxia |
| 09/09/2009 | EP2097397A1 Tetralin analogs having sphingosine 1-phosphate agonist activity |
| 09/09/2009 | EP2097386A2 Substituted dihydroimidazoles and their use in the treatment of tumors |
| 09/09/2009 | EP0999835B1 Imidazole derivatives as mdr modulators |
| 09/09/2009 | CN101528711A Hydantoin derivatives useful as antibacterial agents |
| 09/09/2009 | CN101528710A Aminomethyl-4-imidazoles |
| 09/09/2009 | CN101528709A Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors |
| 09/09/2009 | CN100537527C Aryl and biaryl compounds having MCH modulatory activity |
| 09/09/2009 | CN100537520C N-bridged selective androgen receptor modulators and methods of use thereof |
| 09/09/2009 | CN100537495C Selective ring-opening cross-metathesis of cycloulefins |
| 09/08/2009 | US7585994 used in electrolytes, batteries, capacitors, supercapacitors, and galvanic cells; N,N-dimethylpyrrolidinium trifluoromethanesulfonate; methyl(triethyl)phosphonium trifluoromethanesulfonate |
| 09/08/2009 | US7585976 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting |
| 09/08/2009 | CA2295090C 2,4,4-trisubstituted-1,3-dioxolane antifungals |
| 09/08/2009 | CA2223678C Covalently linked oligonucleotide minor groove binder conjugates |
| 09/08/2009 | CA2141731C Antifungal agents, processes for the preparation thereof, and intermediates |
| 09/03/2009 | WO2009106817A2 Compound |
| 09/03/2009 | WO2009106752A2 Derivatives of 2-heteroaroyl-imidazol[1,2-a]pyridine, preparation thereof and therapeutic application thereof |
| 09/03/2009 | WO2009106751A2 Derivatives of n-heterocyclic-6-heterocyclic-imidazo[l,2- a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | WO2009106750A2 Derivatives of 6-heterocyclic-imidazo[l,2-a]pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | WO2009106749A2 Derivatives of n-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | WO2009106748A2 Derivatives of n-phenyl-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | WO2009106745A2 Method for enantio-selective preparation of sulphoxides |
| 09/03/2009 | WO2009106713A2 New class of cationic lipids for transporting active agents into cells |
| 09/03/2009 | WO2009106640A2 N-benzyl imidazole derivatives |
| 09/03/2009 | WO2009105881A1 Ionic liquids comprising ligands containing positively charged heterocyclic ring useful as catalyst and for metal extractions |
| 09/03/2009 | WO2009070045A3 Imidazole derivatives, process for their preparation, and thier pharmaceutical use |
| 09/03/2009 | US20090221817 Triethylamine was added dropwise to a solution of 2-methylpropane-2-sulfinyl chloride and methyl trans-4-amino-1-cyclohexane carboxylate p-toluenesulfonate in tetrahydrofuran solvent to obtain Methyl trans-4-(2-methylpropane-2-sulfonylamino)cyclohexanecarboxylate; hydrolysis; oxidation; intermediates |
| 09/03/2009 | US20090221547 Immunosuppressant Compounds and Compositions |
| 09/03/2009 | US20090218039 Coloring composition, thermal transfer recording ink sheet, thermal transfer recording method, color toner, inkjet ink, color filter, and dye compound |
| 09/03/2009 | CA2717110A1 Compounds, complexes and uses thereof |
| 09/03/2009 | CA2714058A1 2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease |
| 09/03/2009 | CA2710962A1 Derivatives of 2-heteroaroyl-imidazol[1,2-a]pyridine, preparation thereef and therapeutic application thereof |
| 09/03/2009 | CA2710947A1 Derivatives of 6-heterocyclic-imidazo[1,2-a]pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | CA2710943A1 Derivatives of n-phenyl-imidazo[1,2-.alpha.]pyridine-2-carboxamides, preon thereof and therapeutic application thereof |
| 09/03/2009 | CA2710860A1 Derivatives of n-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | CA2710794A1 Derivatives of n-heterocyclic-6-heterocyclic-imidazo[l,2-.alpha.]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | CA2708988A1 New class of cationic lipids for transporting active agents into cells |
| 09/02/2009 | EP2096490A1 Display element and method of driving the same |
| 09/02/2009 | EP2096104A1 Organic diamines as mGluR7 modulators |
| 09/02/2009 | EP2095819A1 N-benzyl imidazole derivatives and their use as aldosterone synthase inhibitors |
| 09/02/2009 | EP2094669A2 1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors |
| 09/02/2009 | EP2094668A2 4-imidazolines as taar's ligands |
| 09/02/2009 | EP2094667A2 Salts consisting of pentafluorphenylimide anions and their use as ionic liquids |
| 09/02/2009 | EP1844019B1 Methode for the production of losartan |
| 09/02/2009 | CN201301293Y Imidazole synthesis gas continuous feeding pressure self-control device |
| 09/02/2009 | CN101519386A Large conductance calcium-activated K channel opener |
| 09/02/2009 | CN101519376A Synthetic method for aromatic ring bisamide spiro drug template |
| 09/01/2009 | US7582770 3-(2-{1-[(3-Cyclopentyl-1-methyl-2-pyridin-2-yl-1H-indole-6-carbonyl)amino]cyclobutyl}-1-methyl-1H-benzoimidazol-5-yl)acrylic acid; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 09/01/2009 | US7582667 2'-amino-2-methoxy-1,1'-dimethyl-7-bromo-10,11-dihydrospiro[dibenzo[a,d][7]-annulene-5,4'-imidazol]-5'(1'H)-one; treatment of beta -amyloid deposits and neurofibrillary tangles; useful in treating Alzheimer's disease, cognitive impairment, Down's Syndrome, senile dementia, cerebral amyloid angiopathy |
| 09/01/2009 | US7582665 Heterocyclic sulfur compounds and/or prodrugs administered for prophylaxis of thrombocytopenia, anemia or blood disorders |
| 09/01/2009 | US7582657 Vanilloid receptor ligands and their use in treatments |
| 09/01/2009 | US7582654 Antiarrhythmia agents, treating gastrointensinal disorder, gastroesophageal reflux, chronic obstructive pulmonary disease, diabetes;N-cotnaining heterocyclic compound with carbamate or amide groups and indazole ring |
| 08/27/2009 | WO2009050410A3 Carbene and co<sb>2</sb> adducts and use thereof for co<sb>2</sb> extraction |
| 08/27/2009 | WO2006096129A8 Method and use of acidified modified polymers to bind biocides in paints |
| 08/27/2009 | US20090216013 e.g.1,1-Dicyclohexyl-3-[5-(pyridin-2-ylsulfanyl)-thiazol-2-yl]-urea; useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial, in particular, type 2 diabetes |
| 08/27/2009 | US20090215848 Novel imidazolidIn-2-one derivatives as selective androgen receptor modulators (SARMS) |
| 08/27/2009 | US20090215846 (2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides as metalloproteinase inhibitors |
| 08/27/2009 | US20090215795 Cyclic amidine derivatives |
| 08/27/2009 | US20090215730 Antineoplastic compounds and pharmaceutical compositions thereof |
| 08/27/2009 | US20090215728 Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, process for preparing them, medicaments comprising these compounds, and their use |